Hjem › Kronisk myeloid leukæmi › New York
Kronisk myeloid leukæmi kliniske forsøg i New York
15 studier for Kronisk myeloid leukæmi søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1068, Rochester
- Ascentage Investigative Site #1053, Shirley
- Ascentage Investigative Site #1160, Stony Brook
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 21 til 65 · Alle køn · Opdateret 11. sep. 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Columbia University Medical Center New York Presbyterian, New York
RekruttererFase 2
Alder 1 til 18 · Alle køn · Opdateret 2. sep. 2026 · NCT07354074Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT04838041A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- og 9 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545Asciminib Roll-over Study
- Memorial Sloan Kettering, New York
RekruttererFase 4
Alder 7 til 100 · Alle køn · Opdateret 6. jul. 2026 · NCT04877522Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
- University of Rochester NCORP Research Base, Rochester
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT07638007Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
RekruttererTidlig fase 1
Alder 18 til 75 · Alle køn · Opdateret 3. jun. 2026 · NCT03964506A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
- Pfizer New York, New York
RekruttererObservationsstudie
Alder 20 og opefter · Alle køn · Opdateret 14. apr. 2026 · NCT06297161A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. apr. 2026 · NCT05304377A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 12 og opefter · Alle køn · Opdateret 16. mar. 2026 · NCT06994676A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jan. 2026 · NCT06163430ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- Roswell Park Comprehensive Cancer Center, Buffalo
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. nov. 2025 · NCT03595917Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.